Wellnara Post-marketing Surveillance in Japan
NCT01401114
·
clinicaltrials.gov ↗
COMPLETED
Status
411
Enrollment
INDUSTRY
Sponsor class
Conditions
Osteoporosis, Postmenopausal
Interventions
DRUG:
E2/LNG oral (Wellnara, BAY86-5029)
Sponsor
Bayer